SOSN Chair attended the 5th edition of Connected Health Sessions (# SSC16) organized by Ad Scientiam at the Institut du Cerveau et de la Moelle épinière (ICM). During this session, we came back on the CES 2016 seen by two players in e-Health:

• Alexis Matthieu, Co-founder & CEO de Feetme
• Lionel Reichardt, Co-founder & CEO de Pharmageek

During the roundtable, Lionel Reichardt pointed out to us that “Trackers usage time varies between 6 to 18 months and they are abandoned faster and faster”. We can not be satisfied with the simple collection and data visualization. It is with Artificial Intelligence that we will achieve real innovation. To do this, raw data collection is not a problem. The problem becomes real when we start to aggregate data. Real semantic problem. Indeed, we must succeed to aggregate data from multiple sources: patients, medical literature, hospitals … Standard in the Internet of Things begin to emerge. One participant made us also note that “standardization is already advanced in Nordic countries.”

E-Health projects must also face the slowness of validation processes. Clinical validation and implementation of health systems processes are indeed necessary. Compartmentalization is a real problem in France, especially in the health area. Deregulation would create solid products / services and accelerate innovation. As Adscientiam mentionned, “it was easier to start to work with Stanford hospitals than in France”; which is quite unfortunate.

At the CES 2016 “The rise of health actors through big partnerships, such as Johnson & Johnson with Google” particularly marked Lionel Reichardt. The combination of historic health actors with digital specialists will certainly lead to important e-Health projects.

At the end of this session, we asked about the different business models hidden behind e-Health. “At CES, the American insurance companies presented connected objects combined with insurance policies: it is a reality” reflects Alexis Matthew, “In France, we do not agree to accept such models.”

Feetme wants to move towards real health economics showing efficacy of their product. It should be included in the reimbursement of certain pathologies. “The accuracy of care patients will lead to the strenght of the product” explains Alexis Matthieu.

Learn more about organizers and speakers

Ad Scientiam is an application that aims to create tools for the benefit of research and clinical possibilities offered by smartphone and connected objects.

Feetme is an connected orthopaedic sole which measures, thanks to its integrated pressure sensors, the decreased of feet sensitivity – sign of incipient neuropathy for diabetic patients. Feetme aims to achieve at the minimum clinical validation of its product.

There are two facets of Feetme start-up:

One approach, largely prioritized by its founders, very oriented to health of people with diabetes
A second approach oriented fitness / sports

Lionel Reichardt defines himself as “an explorer of the Health e-Transformation”. It performs an intensive monitoring on e-Health through his collaborative blog Pharmageek.